Royalty Pharma to approach Elan shareholders, reuters reports

theflyonthewall.com

Investment firm Royalty Pharma doesn’t want to take "no" for an answer to its $6.6B offer for Irish drugmaker Elan Corp. (ELN), and plans to spend the next few weeks calling Elan shareholders about its February 18 offer, sources say, reports Reuters.

View Comments (1)